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This Month in the Journal
What Is Causation?, by Page et al. (p. 711)
This month in the Journal, Grier Page and colleagues
discuss their views on concluding causation in complex
disease. Because biological causation can often not be
proven in these diseases, it can be hard to move beyond
a ﬁnding of association between a marker and a complex
disease to a conclusion that the polymorphism actually
causes disease. They believe that it is the responsibility of
investigators to systematically remove confounders and
sources of error, bias, and disequilibria before genetic
causation is suggested. They also encourage the report-
ing of all relevant data to better allow biases to be iden-
tiﬁed and meta-analyses to be performed so that conclu-
sions on causation are nearer at hand.
Multiple Origins of Ashkenazi Levites, by Behar et al.
(p. 768)
Membership in three male castes in the Jewish commu-
nity—the Cohanim, Levites, and Israelites—is determined
by paternal descent. The Cohanim are considered to be
the descendants of Aaron, Moses’s brother, whereas the
Levites are the descendants of Levi, a son of Jacob. Behar
et al. ﬁnd evidence of an unexpected event in the history
of the Ashkenazi Levites, through an investigation of their
paternal genetic history. Using the nonrecombining por-
tion of the Y chromosome, they compare this population
with other Jewish groups and neighboring non-Jewish
populations. They ﬁnd a haplogroup, R1a1, in over half
of the Ashkenazi Levite samples that is at similarly high
frequencies in Slavonic populations but at low frequen-
cies in other Jewish populations.When compared in terms
of genetic similarity, the Ashkenazi Levites cluster more
with the Slavonic populations than with other Jewish
populations, including Sephardi Levites. The clustered
pattern of haplotypes within R1a1 is consistent with a
founding event that occurred fairly recently and involved
a small number of individuals. On the basis of these
results, one could speculate that not all Levites are de-
scendants of Levi but, rather, that there was a non-Jewish
introgression of a small number of European individuals
into the Ashkenazi Levite population and that their chil-
dren were given Levite status. Modern-day descendants
of these converts make up a large proportion of the Ash-
kenazi Levites today.
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CMG2 Mutations Cause JHF and ISH, by Hanks et al.
(p. 791), and CMG2 Mutations in JHF and ISH, by
Dowling et al. (p. 957)
Juvenile hyaline ﬁbromatosis (JHF) and infantile systemic
hyalinosis (ISH) share many clinical features, including
the deposition of an amorphous, hyaline (glassy and
transparent) material of unknown origin. Both present
with joint contractures, gingival hypertrophy, and papulo-
nodular skin lesions, although ISH is amore severe disease
that is often associated with death in infancy. Hanks et
al. and Dowling et al. report that these diseases both
result from mutations in capillary morphogenesis pro-
tein 2 (CMG2). Little is known about the physiological
role of CMG-2, other than the fact that it seems to be
involved in binding extracellular matrix proteins, such
as laminin, and the fact that it can serve as an anthrax
toxin receptor. Because of the potential role of CMG-2
in cell-cell and cell-matrix interactions, Dowling et al.
examined the ability of patient ﬁbroblasts to attach and
grow on different substrates. They found that, in con-
trast to wild-type cells, ﬁbroblasts from affected indi-
viduals were unable to attach to a laminin matrix. In
the body, a disruption of cell-matrix interactions such
as this could be the cause of JHF and ISH, but a deﬁnitive
molecular explanation for the difference between ISH and
JHF has not been found.
Alu Repeats and Human Duplications, by Bailey et al.
(p. 823)
Compared with the genomes of other organisms that have
been sequenced, the human genome is enriched for large
blocks of segmental duplications. These duplications are
biased toward genic sequences and are generally sepa-
rated by at least 1 Mb of intervening sequence, rather
than being tandemly arranged. To gain insight into the
mechanism that might have generated this pattern of du-
plications, Bailey et al. did a comprehensive, genomewide
survey of the duplication sequences and their junctions.
They realized that the segmental duplications were en-
riched for Alu elements compared with the genome av-
erage and that many of the duplications terminatedwithin
Alus. This ﬁnding, along with the fact that the Alu ele-
ments at the duplication junctions show higher levels of
divergence than those internal to the duplicated se-
quence, suggests that the Alus may have played a role
in the origin and expansion of segmental duplications
in the human genome through an Alu-mediated recom-
bination mechanism. The observed enrichment was al-
most entirely accounted for by the younger Alu subfami-
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lies, leading the authors to propose that the primate-
speciﬁc burst of Alu retroposition activity that occurred
35–40 million years ago may have been responsible for
the initial excess of segmental duplication events and
that this kicked off cycles of nonallelic homologous re-
combination that led to the expansion of segmental du-
plications and resulted in the pattern of duplications we
see today.
Four BP1-BP2 Genes in the PWS/AS Domain, by Chai
et al. (p. 898), and NIPA1 Mutations Cause SPG6
HSP, by Rainier et al. (p. 967)
Prader-Willi (PWS) and Angelman syndromes (AS) are
caused by parent-of-origin–speciﬁc loss of expression of
genes at chromosome 15q11-q13. Whereas PWS results
from the loss of a set of paternally inherited alleles in
this region, AS is associated with the loss of maternally
inherited alleles. Because the full extent of the imprinted
region is not known, Chai et al. examined 15q11-q13 and
found four additional genes, two known and two un-
known. These are CYFIP1, GCP5, NIPA1, and NIPA2
(for nonimprinted in PWS/AS). As their names imply,
NIPA1 and NIPA2 were found not to be imprinted,
although the mouse orthologs of these genes, along with
Cyﬁp1, show asynchronous replication that was random
with respect to parental origin, a property generally as-
sociated with monoallelic gene expression. The NIPA
genes are highly conserved in vertebrate species, al-
though it appears that a transposition has altered the
relative position of this four-gene block in humans. In
addition to PWS/AS, this region is associated with other
chromosomal rearrangements, including duplications,
triplications, and inverted duplications. These genes are
therefore candidates for involvement in the phenotypes
associated with these rearrangements, as well as with
other disorders that map to this region, including he-
reditary spastic paraplegia (SPG6).
In fact, Rainier et al. used the original SPG6-linked
family to determine whether NIPA1, NIPA2, GCP5, or
CYFIP1 plays a role in hereditary spastic paraplegia
(HSP). They found amissensemutation (T45R) inNIPA1
that segregated with disease in this large pedigree. The
mutated residue is conserved in mouse, chicken, and ﬁsh,
and it is located at the end of the ﬁrst of nine trans-
membrane domains in the protein. NIPA1 was also
sequenced in probands from an additional 68 families
with HSP, as well as 13 suspected cases of sporadic HSP.
The T45R mutation was found in an additional kindred,
although the two mutation-carrying families do not ap-
pear to share ancestry, nor is there a shared haplotype
in the region, so it appears that the mutation arose in-
dependently in the two families. Because the function
of NIPA1 is not yet known, it is unclear how this
mutation might lead to HSP. The fact that individuals
with PWS or AS often have deletions that include NIPA1
but do not exhibit progressive spastic paraplegia indi-
cates that NIPA1 haploinsufﬁciency does not cause this
phenotype.
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